Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Shinjini"


25 mentions found


Mastercard third-quarter profit rises
  + stars: | 2023-10-26 | by ( ) www.reuters.com   time to read: +1 min
Credit card is seen in front of displayed Master Card logo in this illustration taken, July 15, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsOct 26 (Reuters) - Mastercard (MA.N) on Thursday reported a rise in third-quarter profit, as consumer spent on travel and entertainment. The company reported a profit of $3.2 billion, or $3.39 per share, for the three months ended Sept. 30, compared with $2.5 billion, or $2.58 per share, a year earlier. Wage growth has helped customers persist with their spending habits on travel, shopping and entertainment despite still high inflation. Reporting by Niket Nishant in Bengaluru; Editing by Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.
Persons: Dado Ruvic, Niket, Shinjini Organizations: REUTERS, Mastercard, U.S . Federal, Thomson Locations: Bengaluru
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. Merck raised Lagevrio full-year sales forecast to $1.3 billion. Third-quarter sales of Merck's top-selling cancer immunotherapy, Keytruda, stood at $6.34 billion, surpassing analysts' average estimate of $6.22 billion. Gardasil, its vaccine to prevent cancers caused by human papillomavirus (HPV), generated sales of $2.59 billion, rising 13% but missing analysts' average estimate of $2.69 billion. The company posted sales of $15.96 billion in the reported quarter, compared to the average analyst estimate of $15.3 billion.
Persons: Brendan McDermid, Molnupiravir, Merck, Wells, Mohit Bansal, drugmaker, Michael Erman, Leroy Leo, Bill Berkrot Organizations: Merck, Co, REUTERS, Merck & Co, Pfizer's, Thomson Locations: Rahway , New Jersey, U.S, Japan, United States, EU
"Short term, if you're visiting a smaller biotech customer, what you're seeing is concerns about when the funding environment is going to improve. On the call, finance chief Stephen Williamson said core revenue growth and adjusted profit in 2024 will be similar to that in 2023. It also forecast 2023 adjusted profit of $21.50 per share, below analysts' estimates of $22.28. The medical equipment maker forecast adjusted earnings of $21.75 per share in 2024, short of analysts' estimates by $2.23. Third-quarter revenue of $10.57 billion missed analysts' expectations of $10.60 billion while adjusted profit of $5.69 per share topped estimates of $5.61, according to LSEG data.
Persons: Brian Snyder, Marc Casper, Stephen Williamson, Raymond James, Andrew Cooper, Bhanvi, Shinjini Ganguli, Shounak Dasgupta, Sriraj Organizations: REUTERS, Agilent Technologies, Reuters, Thomson Locations: Waltham , Massachusetts, U.S, China, Bengaluru
Oct 25 (Reuters) - U.S. defense contractor Teledyne Technologies (TDY.N) on Wednesday raised its full-year profit forecast after reporting better-than-expected quarterly earnings on strong performance in its business that makes monitoring and control equipment. Teledyne, which owns drone maker FLIR systems, also reported an 8.1% rise in its aerospace and defense business amid rising geopolitical tensions. The Pentagon has awarded lucrative contracts to refill its depleted weapons stockpile after shipping aid to Ukraine, adding to sales at U.S. defense contractors. California-based Teledyne expects a full-year profit of $15.82 to $15.96 per share, compared with its previously forecast range of $15.66 to $15.88. In the third quarter ended Oct. 1, Teledyne reported a quarterly profit of $5.05 per share, compared with analysts' estimates of $4.76.
Persons: Aishwarya Jain, Shinjini Organizations: Teledyne Technologies, Teledyne, Pentagon, U.S, Thomson Locations: Ukraine, California
Amphenol forecasts dour Q4 on weak telecom spending
  + stars: | 2023-10-25 | by ( ) www.reuters.com   time to read: +1 min
Oct 25 (Reuters) - Electronic components maker Amphenol (APH.N) forecast fourth-quarter revenue below market estimates on Wednesday, as its clients across industries cut spending in the face of high borrowing costs. Telecom providers, one of Amphenol's biggest customers, have cut orders for communications equipment after a rush to build out their 5G networks over the past two years. The communications solutions business, which produces fiber optic products and antennas, saw a decline of nearly 16% in third-quarter net sales to $1.28 billion. Third-quarter adjusted earnings of 78 cents per share also beat estimates of 74 cents. Amphenol forecast adjusted earnings between 75 cents and 77 cents per share for the fourth quarter, in line with estimates of 76 cents per share.
Persons: Amphenol, Arsheeya, Shinjini Organizations: Telecom, Thomson Locations: Connecticut, Bengaluru
Through the lawsuit, Attorney General James is seeking restitution for investors and "disgorgement of ill-gotten gains," along with a ban on all the three cryptocurrency firms from the financial investment industry in New York. At the heart of the lawsuit is a program that Gemini ran in partnership with Genesis, dubbed "Gemini Earn". Gemini did not reveal any of this information to the investors of Gemini Earn, she added. Genesis and Gemini have clashed several times over the past few months, including over Gemini Earn. DCG said it was blindsided by the attorney general's complaint and the company's CEO Barry Silbert said the lawsuit had "baseless allegations".
Persons: Dado Ruvic, Letitia James, cryptocurrency, Sam Bankman, James, Gemini, Genesis, Mark Zuckerberg, DCG, Barry Silbert, Silbert, Niket, Krishna Chandra Eluri, Shinjini, Shounak Organizations: REUTERS, New York, Genesis Global, Digital Currency Group, Gemini, Meta, Arrows, Thomson Locations: New York, Alameda, Bengaluru
Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsOct 19 (Reuters) - Bristol Myers Squibb (BMY.N) said on Thursday the injectable form of its blockbuster cancer drug Opdivo met the main goal in trial that had patients with a type of kidney cancer. "We believe this new option, given as a single injection administered in less than five minutes, could transform the treatment experience for both patients and physicians," Gina Fusaro, an executive at Bristol Myers Squibb, said. The trial also showed a non-inferior response rate to the subcutaneous drug, compared to its intravenous form. Bristol Myers now plans to discuss with regulators the next steps for submission and approval of subcutaneous injections for multiple types of cancers.
Persons: Bristol Myers, Dado Ruvic, Opdivo, Gina Fusaro, Roche, Johnson, Helen Torley, Leroy Leo, Anil D'Silva, Shinjini, Shounak Organizations: Bristol, Bristol Myers Squibb, REUTERS, Therapeutics, U.S, Thomson Locations: Bengaluru
India's ITC misses profit estimates as competition, costs rise
  + stars: | 2023-10-19 | by ( ) www.reuters.com   time to read: +2 min
REUTERS/Vivek Prakash/File Photo Acquire Licensing RightsBENGALURU/CHENNAI, Oct 19 (Reuters) - India's ITC (ITC.NS) reported a smaller-than-expected rise in its second-quarter profit on Thursday, as the consumer goods major grappled with stiff competition from smaller rivals and higher prices of some commodities. Dove-soapmaker Hindustan Unilever said earlier in the day it lost some market share in its mass segment - comprising lower-priced products - due to competition. The tobacco-to-hotels conglomerate's profit still rose 10% to 49.27 billion rupees ($592.81 million), but missed analysts' average estimate of 49.54 billion rupees, according to data from LSEG. Revenue from operations rose 3% to 177.05 billion rupees, helped by a 10% surge in its cigarettes business. Other consumer goods majors Nestle India (NEST.NS) and Hindustan Unilever eased past quarterly earnings estimates earlier on Thursday, as city dwellers spent more on affordable pick-me-ups like cookies and coffee.
Persons: Vivek Prakash, Shirish Pardeshi, Navamya Ganesh Acharya, Varun, Anil D'Silva Organizations: ITC, REUTERS, Hindustan Unilever, Centrum Broking, Nestle India, Varun Vyas, Thomson Locations: Mumbai, BENGALURU, CHENNAI, LSEG ., Bengaluru, Praveen, Chennai
REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsOct 18 (Reuters) - Abbott Laboratories (ABT.N) said the market was overestimating the hit to sales of its glucose monitoring products from growing popularity of new diabetes drugs, adding the treatments could end up boosting sales of the medical device maker. The company's shares have dropped 16% this year, mainly on concerns that new GLP-1 diabetes drugs such as Novo Nordisk's Ozempic and Eli Lilly's Mounjaro could eat into the sales of its continuous glucose monitoring (CGM) devices. Hurdles in health insurance reimbursement and pricing could, however, keep market growth for GLP-1 drugs limited to a small number of patients in the near term, Abbott CEO Robert Ford said on Wednesday. Third-quarter sales of FreeStyle Libre, Abbott's CGM device used by diabetes patients, jumped 30.5% to $1.4 billion, lifting Abbott's shares 3% in morning trade. The numbers helped Abbott's medical device sales that stood at $4.25 billion, beating analysts' estimates of $4.16 billion, according to LSEG data.
Persons: Brendan McDermid, Nordisk's Ozempic, Eli Lilly's, Abbott, Robert Ford, Ford, Vijay Kumar, Pratik Jain, Leroy Leo, Anil D'Silva, Shounak Dasgupta, Shinjini Organizations: Abbott, New York Stock Exchange, REUTERS, Abbott Laboratories, Nordisk's, Thomson Locations: New York City, U.S, GLP, Bengaluru
(Reuters) - US Bancorp beat estimates for third-quarter profit on Wednesday, as higher interest income from loans offset a hit from bigger credit-loss provisions. The U.S. Federal Reserve's aggressive monetary tightening over the past year to tame inflation has boosted profits at consumer-facing banks as customers pay a higher rate on their mortgages and credit card debt. Net interest income, which is the difference between what banks earn from lending and pay out on deposits, for the third quarter ended Sept. 30 rose 10.7% to $4.27 billion for USB. But even though lenders have reaped a windfall from interest income, the 'higher-for-longer' interest rate environment has soured the outlook for the economy as consumers feel the burn of higher credit costs and lower household budgets. USB set aside $515 million as provisions anticipating more loan defaults, compared with $362 million a year earlier.
Persons: Pritam Biswas, Krishna Chandra Eluri Organizations: Reuters, US Bancorp, U.S Locations: Federal, Bengaluru
REUTERS/Phil Noble/File Photo Acquire Licensing RightsOct 18 (Reuters) - Shares in AstraZeneca (AZN.L) fell more than 4% on Wednesday after a data abstract on its experimental precision drug's use in lung cancer patients in a late-stage trial disappointed some analysts. Fernandez added that progression-free survival in lung cancer patients came in below expectations. Barclays analyst Emily Field also said in a note that safety looked better than expected for lung cancer patients and the data abstracts were "collectively positive" for AstraZeneca. London-listed shares of AstraZeneca were down 3.7% at 1219 GMT, while the broader STOXX Health Care (.SXDP) index was off 1%. Shares of AstraZeneca's Japanese partner Daiichi Sankyo (4568.T), which is jointly developing the cancer drug, closed 4.6% lower on Tuesday.
Persons: Phil Noble, datopotamab deruxtecan, Jefferies, Stephen Barker, Barker, Seamus Fernandez, Fernandez, Emily Field, GSK's, Danilo Masoni, Maggie Fick, Bhanvi, Shinjini Organizations: AstraZeneca, REUTERS, European Society for Medical, Friday, Guggeinheim, Barclays, AstraZeneca ., Thomson Locations: Macclesfield, Britain, Madrid, AstraZeneca . London, U.S, Milan, London, Bengaluru
[1/2] Geoffrey Ballotti, CEO of Wyndham Hotels & Resorts, Inc. rings the opening bell at the New York Stock Exchange (NYSE) in New York City, U.S., June 5, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsOct 17 (Reuters) - Choice Hotels (CHH.N) on Tuesday proposed to acquire Wyndham Hotels and Resorts (WH.N) for about $7.8 billion in a cash and stock deal that would create a U.S. budget hotel giant. Demand for affordable hotels such as Choice and Wyndham are on the rise as persistent high inflation and recession sap consumer spending on travel. Choice offered Wyndham shareholders $90.00 per share, including $49.50 in cash and 0.324 shares of its common stock for each Wyndham share owned. As of yesterday's close, Choice had a total market capital of $6.29 billion, Wyndham's stood at $5.82 billion.
Persons: Geoffrey Ballotti, Brendan McDermid, Wyndham, Wyndham's, Priyamvada, Shinjini Organizations: Wyndham Hotels & Resorts, Inc, New York Stock Exchange, REUTERS, Wyndham Hotels, Resorts, Wyndham, Reuters, Thomson Locations: New York City, U.S, Bengaluru
The Bank of New York Mellon Corp. building at 1 Wall St. is seen in New York's financial district March 11, 2015. Last week, JPMorgan (JPM.N), Wells Fargo (WFC.N) and Citigroup (C.N) beat analysts' estimates for the latest quarter and raised FY23 interest income forecasts. BNY Mellon's net interest revenue for the reported quarter jumped nearly 10% to $1.02 billion, compared with $926 million a year earlier. While higher interest rates have benefited banks, they have also deepened fears of more loan defaults, prompting lenders to maintain reserves on the sidelines. New York-based BNY Mellon kept aside $3 million in provision for credit losses for the quarter.
Persons: Brendan McDermid, Banks, BNY Mellon, Jaiveer Singh, Shinjini Organizations: of New York Mellon Corp, REUTERS, Bank of New York Mellon Corp, U.S . Federal Reserve, JPMorgan, Citigroup, Thomson Locations: Wells Fargo, New York, Bengaluru
Ineos Chair Jim Ratcliffe would pay over $1.5 billion for the stake in Manchester United if his bid for the soccer club is accepted by the Glazer family that controls it, Reuters reported on Sunday, citing a person familiar with the matter. "Investors are clearly reacting with disappointment to expectations the Qatar deal for Manchester United will not go through," said Susannah Streeter, head of money and markets at Hargreaves Lansdown. "Expectations for a flood of fresh funding into Man U's coffers for a new stadium and new players are being revised." Jassim informed the Glazer family a few days ago that he will not raise his bid of more than $6 billion for Manchester United, which had a market capitalization of $3.26 billion as of Friday's close. Reporting by Sruthi Shankar in Bengaluru; Editing by Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.
Persons: Jim Ratcliffe, Qatar's Sheikh Jassim bin Hamad al Thani, Ineos, Glazer, Susannah Streeter, Hargreaves Lansdown, Jassim, Sruthi Shankar, Shinjini Organizations: Manchester United, Reuters, Premier League, Hargreaves, Thomson Locations: Qatar, Bengaluru
Wall Street's three major indexes opened higher but lost ground after a preliminary reading on U.S. consumer sentiment showed a sharp fall in October. The moves in bonds, equities and oil reflect worries about deteriorating consumer sentiment, the global economy and geopolitical conflict, she added. However, for the week the S&P 500 registered a 0.45% gain for its second weekly advance in a row. The S&P 500 Banks index (.SPXBK) pared gains as the day wore on to close up 0.6% after rising as much as 3.4% to a three-week high. The S&P 500 posted 12 new 52-week highs and 20 new lows; the Nasdaq Composite recorded 28 new highs and 335 new lows.
Persons: Brendan McDermid, Wells, Wall, Dow, Israel, Lauren Goodwin, Goodwin, Patrick Harker, Todd Vasos, Jeff Owen, advancers, Sinéad Carew, Shashwat Chauhan, Ankika Biswas, Shounak Dasgupta, Anil D'Silva, Shinjini Ganguli, Richard Chang Organizations: New York Stock Exchange, REUTERS, JPMorgan, Dow, Nasdaq, The United Nations, Treasury, New York Life Investments, Dow Jones, JPMorgan Chase, Citigroup, Federal Reserve Bank of Philadelphia, BlackRock, Dollar, Boeing, NYSE, Thomson Locations: New York City, U.S, Wells Fargo, Gaza, Israel, BLK.N, Bengaluru
Oct 13 (Reuters) - A union coalition for Kaiser Permanente healthcare workers reached a tentative labor deal with the hospital system on Friday that included across-the-board wage increases after 75,000 members took part in a three-day strike last week. The strike was the largest recorded among medical workers and included nurses, medical technicians and support staff at hundreds of Kaiser hospitals and clinics from California to Virginia. "I’m heartened to see healthcare workers and their employers take this critical step towards securing the pay, benefits, and working conditions these heroes deserve," President Joe Biden said in a statement. The Kaiser union coalition had threatened to strike again for a week starting Nov. 1. The union had said Kaiser would need to hire 10,000 new healthcare workers to fill current vacancies.
Persons: Julie Su, Biden, Joe Biden, Kaiser, Su, Manas Mishra, Leroy Leo, Steve Gorman, Arun Koyyur, Shinjini, Maju Samuel, Jonathan Oatis Organizations: Kaiser Permanente, Labor, Tenet Healthcare, District of Columbia, Writers Guild of America, United Auto Workers, Detroit, Thomson Locations: California, Virginia, San Francisco Bay, Bengaluru, Los Angeles
Microsoft-Activision: Ubisoft deal helps win Britain's nod
  + stars: | 2023-10-13 | by ( ) www.reuters.com   time to read: +1 min
Oct 13 (Reuters) - Britain's antitrust regulator on Friday cleared Microsoft's (MSFT.O) acquisition of "Call of Duty" maker Activision Blizzard (ATVI.O) after the restructured deal substantially addressed its earlier concerns. In August, Activision agreed to sell its non-European streaming rights to Ubisoft Entertainment (UBIP.PA) to get the biggest deal yet in video-gaming past Britain's Competition and Markets Authority (CMA). "We have now crossed the final regulatory hurdle to close this acquisition, which we believe will benefit players and the gaming industry worldwide," Microsoft President Brad Smith said. The company had in July extended the deadline to close the deal by Oct. 18. Here is a snapshot of key events in the Microsoft-Activision saga:Reporting by Tiyashi Datta, Jaspreet Singh and Yadarisa Shabong in Bengaluru; Editing by Anil D'Silva, Shinjini Ganguli and Varun H KOur Standards: The Thomson Reuters Trust Principles.
Persons: Brad Smith, Tiyashi Datta, Jaspreet Singh, Yadarisa, Anil D'Silva, Shinjini Organizations: Activision, Ubisoft Entertainment, Markets Authority, Microsoft, Thomson Locations: Bengaluru
A view of a fresh food aisle at a Dollar General store in Norridge, Chicago, U.S., August 24, 2021. With Vasos' appointment, Dollar General hopes "to restore stability and confidence" in the company, whose stock has lost more than half its value so far this year. But for now, the company trimmed its annual sales and profit estimates for a third time, just over a month after it forecast a steep drop in annual profit and missed market expectations for second-quarter results. Vasos "is acutely aware of the challenges facing our business and the industry more broadly" Dollar General said, adding his appointment was effective immediately. It tightened the range of its annual net sales growth outlook to 1.5% to 2.5%, from a prior range of 1.3% to 3.3% growth.
Persons: Richa Naidu, Todd Vasos, Jeffery Owen, Vasos, Savyata Mishra, Maju Samuel, Shinjini Organizations: REUTERS, Thomson Locations: Norridge , Chicago, U.S, Bengaluru
Oct 11 (Reuters) - Permian Basin dealmaking has got a major boost with Exxon Mobil (XOM.N) set to buy rival Pioneer Natural Resources (PXD.N) for nearly $60 billion, which will make it the biggest producer in the largest U.S. oilfield. Permian is a prime target for producers looking to increase their inventory. The shale patch, which lies between Texas and New Mexico, has robust infrastructure and is known for high productivity and large undeveloped reserves. Below is a list of Permian deals so far this year:Reporting by Mrinalika Roy, Tanay Dhumal and Sourasis Bose in Bengaluru; Editing by Sriraj Kalluvila, Shinjini Ganguli and Vinay DwivediOur Standards: The Thomson Reuters Trust Principles.
Persons: Mrinalika Roy, Tanay, Sourasis Bose, Sriraj Kalluvila, Shinjini Ganguli, Vinay Dwivedi Organizations: Exxon Mobil, Natural Resources, Thomson Locations: Texas, New Mexico, Bengaluru
Men walk past a 1 Malaysia Development Berhad (1MDB) billboard at the funds flagship Tun Razak Exchange development in Kuala Lumpur March 1, 2015. REUTERS/Olivia Harris/ File Photo Acquire Licensing RightsOct 11 (Reuters) - Goldman Sachs Group (GS.N) is suing Malaysia in a UK court, a source familiar with the matter told Reuters, as tensions escalate over a settlement linked to its role in the 1MDB investment-fund scandal. The arbitration has been filed with the London Court of International Arbitration (LCIA), the source said. In 2020, Goldman Sachs had agreed to pay $3.9 billion to settle Malaysia's criminal probe over the U.S. investment bank's role in the multibillion-dollar 1MDB scandal. The United States has been returning funds it has recovered from seized assets that were allegedly bought with stolen 1MDB money.
Persons: Olivia Harris, Goldman Sachs, Najib Razak, Goldman, Samrhitha, Shinjini Organizations: Malaysia Development Berhad, Tun, Exchange, REUTERS, Goldman Sachs, London Court, International, Government, Reuters, Malaysian, Prosecutors, United, Bloomberg News, Thomson Locations: Malaysia, Kuala Lumpur, U.S, United States, Bengaluru
A screen displays the logo for HP Inc. at the New York Stock Exchange (NYSE) in New York, U.S., November 18, 2019. REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsOct 10 (Reuters) - HP Inc (HPQ.N) on Tuesday forecast fiscal 2024 earnings largely in line with estimates and raised its annual dividend, reflecting stabilizing demand in the personal computers market. Shares of Palo Alto, California-based HP were up more than 2% in trading after the bell. The board has approved an increase to the planned dividend amount to $1.10 per share, reflecting a 5% increase from the prior dividend, the company said. The company expects its 2024 adjusted earnings in the range of $3.25 to $3.65 per share, largely in line with analyst estimates of $3.47, according to LSEG data.
Persons: Brendan McDermid, Enrique Lores, Samrhitha, Maju Samuel, Shinjini Organizations: HP Inc, New York Stock Exchange, REUTERS, Companies, HP, Lenovo, HK, Dell Technologies, Palo, Thomson Locations: New York, U.S, Palo Alto , California, Bengaluru
Top issues in Detroit Three's negotiations with UAW
  + stars: | 2023-10-10 | by ( ) www.reuters.com   time to read: 1 min
Oct 10 (Reuters) - The United Auto Workers (UAW) secured a "major breakthrough" in labor talks with the Detroit Three automakers as General Motors (GM.N) made some concessions by allowing workers at joint-venture battery plants to be covered by union contracts. Here is a look at the top talking points, and how negotiations have progressed three weeks after the strike began, according to UAW President Shawn Fain and the companies:Source: Fain's statement, company statementsReporting by Niket Nishant and Abhinav Parmar in Bengaluru; Editing by Shinjini Ganguli and Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.
Persons: Shawn Fain, Niket Nishant, Abhinav Parmar, Shinjini Ganguli Organizations: United Auto Workers, UAW, Detroit, General Motors, Thomson Locations: Bengaluru
[1/2] Healthcare workers strike in front of Kaiser Permanente Los Angeles Medical Center, as more than 75,000 Kaiser Permanente healthcare workers go on strike from October 4 to 7 across the United States, in Los Angeles, California, U.S. October 4, 2023. The Coalition of Kaiser Permanente Unions said on Monday it has served the company notice that a weeklong "follow-up strike is possible" starting Nov. 1 unless the two sides come to a settlement beforehand. The company did not have an immediate response to the unions' latest strike deadline. The strike, which ran for three days, marked the largest work stoppage to date in the healthcare sector. Kaiser said it kept its hospitals and emergency departments open during the walkout, staffed by doctors, managers and "contingency workers."
Persons: Julie Su, Su, Kaiser, Steve Gorman, Sriparna Roy, Caroline Humer, Shinjini Ganguli, Matthew Lewis Organizations: Healthcare, Kaiser Permanente Los Angeles Medical Center, Permanente, REUTERS, Kaiser Permanente, Coalition, Kaiser Permanente Unions, Union, Kaiser, District of Columbia, Thomson Locations: United States, Los Angeles , California, U.S, Kaiser, California, California , Oregon, Washington, , Colorado, Virginia, Seattle, Los Angeles, Bengaluru
Following are the steps taken by the companies ranging from airlines to banks:TRAVELSeveral Asian, European and U.S. airlines have suspended direct flights to Tel Aviv. Delta Air Lines (DAL.N):The airline said it continues to monitor events in the region and has made the decision to cancel Delta-operated Tel Aviv flights through Oct. 31. Goldman Sachs (GS.N):The bank's employees at its office in Tel Aviv have been asked to work from home, a spokesperson said. TECHNvidia (NVDA.O):The world's largest maker of chips used for artificial intelligence and computer graphics said it had canceled an AI summit scheduled for Tel Aviv next week. CONSUMER AND RETAILH&M (HMb.ST):The clothing company said its local franchise partner has temporarily closed all stores in Israel.
Persons: Amir Cohen, El, Goldman Sachs, Morgan Stanley, Gautam Adani's, Jensen Huang, PHARMA Eli Lilly, Lilly, Priyamvada C, Mehr Bedi, Ananya Mariam Rajesh, Khushi, Jaiveer Singh, Samrhitha, Helen Reid, Sriraj Kalluvila, Shounak Dasgupta, Shinjini Organizations: Gaza, REUTERS, Palestinian, Hamas, Tel Aviv . Delta Air Lines, Royal, Chevron, JPMorgan Chase, Reuters, Bank of America, Bloomberg News, FedEx, TECH Nvidia, Tel, Inditex SA, PHARMA, Thomson Locations: Sderot, Israel, U.S, Tel Aviv, Royal Caribbean, Haifa Port, Zara, Bengaluru, London
A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, August31, 2023. The survey of 502 employers by Accolade (ACCD.O), a company that provides healthcare programs for employers, and research firm Savanta said 43% of the employers it polled could cover GLP-1 drugs in 2024 compared to 25% that cover them now. Nearly all the companies that are covering GLP-1 drugs plan to keep covering them next year, according to the survey. Employers that cover weight-loss drugs are facing a spike in their healthcare costs because of the growing popularity of Wegovy. Benefits consultant Aon (AON.N) said 1 percentage point of the 8.5% increase in employer healthcare costs it predicted for next year would be driven by employee take-up of weight-loss drugs.
Persons: Victoria Klesty, Savanta, James Wantuck, Ozempic, Eli Lilly's, Leroy Leo, Shinjini Organizations: REUTERS, Novo Nordisk, Accolade, Employers, Novo, Novo Nordisk's Wegovy, Thomson Locations: Oslo, Norway, August31, Victoria, Novo, Novo Nordisk's, United States, Bengaluru
Total: 25